PubMed for id: 317758

Year	Number of Results
2002	1
2005	1
2007	1
2008	1
2009	2
2010	3
2011	1
2012	3
2013	6
2014	5
2015	6
2016	5
2017	5
2018	11
2019	11
2020	7
2021	6
2022	7
2023	6

1

[Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].

Umeki Y, Ikeda M, Nakahara W, Asako M, Matsuoka Y, Terakawa T, Matsunaga H, Tadokoro R, Sekiguchi M, Matsui T, Oka K, Higuchi K, Sawada A, Inoue M, Ueda S. Umeki Y, et al. Rinsho Ketsueki. 2023;64(3):209-213. doi: 10.11406/rinketsu.64.209. Rinsho Ketsueki. 2023. PMID: 37019675 Japanese.

2

Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis.

Chang L, Zhang C, Lu J, Shen J, Hamal K, Liu D. Chang L, et al. Infect Drug Resist. 2023 Mar 16;16:1545-1559. doi: 10.2147/IDR.S402040. eCollection 2023. Infect Drug Resist. 2023. PMID: 36960391 Free PMC article.

3

Refractory Hydroa Vacciniforme-like Lymphoma: Biological Insights from Morphoproteomic Analysis.

Goswamy R, Ajufo H, Maiti A, Brown R, Juneja H, Apostolidou E. Goswamy R, et al. Int J Hematol Oncol Stem Cell Res. 2022 Jul 1;16(3):177-183. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 36694700 Free PMC article.

4

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.

Grześk E, Kołtan S, Dąbrowska A, Urbańczyk A, Małdyk J, Małkowski B, Bogiel T, Dębski R, Czyżewski K, Wysocki M, Styczyński J. Grześk E, et al. Front Immunol. 2022 Aug 5;13:915986. doi: 10.3389/fimmu.2022.915986. eCollection 2022. Front Immunol. 2022. PMID: 35990691 Free PMC article.

5

Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.

Xu W, Tan J, Cai C, Lei L, Cao X, Zhou H, Xu M. Xu W, et al. Pediatr Dermatol. 2022 May;39(3):372-375. doi: 10.1111/pde.14938. Epub 2022 Feb 22. Pediatr Dermatol. 2022. PMID: 35194837

6

Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.

Feng X, Li F, Zhang Y, Wang L. Feng X, et al. Pediatr Dermatol. 2021 Sep;38(5):1387-1388. doi: 10.1111/pde.14808. Epub 2021 Sep 24. Pediatr Dermatol. 2021. PMID: 34561883

7

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in an Adult Patient With Chronic Lymphocytic Leukemia.

Chee A, Wood B, Sadler G, Cull G. Chee A, et al. J Med Cases. 2020 Nov;11(11):366-369. doi: 10.14740/jmc3576. Epub 2020 Sep 23. J Med Cases. 2020. PMID: 34434348 Free PMC article.

8

Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.

López de Cáceres CVB, Rodrigues-Fernandes CI, Rendón Henao J, Morais TML, Soares CD, de Almeida OP, Fonseca FP, Delgado-Azañero W. López de Cáceres CVB, et al. J Oral Pathol Med. 2021 Jul;50(6):530-539. doi: 10.1111/jop.13203. Epub 2021 Jun 29. J Oral Pathol Med. 2021. PMID: 34097774

9

Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA.

Oh SJ, Lee J, Park JH, Lee JH, Cho J, Ko YH, Lee D. Oh SJ, et al. Ann Dermatol. 2021 Jun;33(3):222-227. doi: 10.5021/ad.2021.33.3.222. Epub 2021 May 4. Ann Dermatol. 2021. PMID: 34079181 Free PMC article.

10

Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.

Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M. Wang X, et al. J Dermatol. 2021 Sep;48(9):1315-1326. doi: 10.1111/1346-8138.15944. Epub 2021 May 13. J Dermatol. 2021. PMID: 33982815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year